15 search results for: asthma

Pediatric <b>Asthma</b> Trajectory and Clinical Remission
expert video

Pediatric Asthma Trajectory and Clinical Remission

Type 2 Inflammation
Join Dr. Leonard Bacharier as he discusses the definition of clinical remission in pediatric asthma and how it can represent a potential target in pediatric asthma management.
View more
Mucus Plugging as a Potential Target in <b>Asthma</b> Management
expert video

Mucus Plugging as a Potential Target in Asthma Management

Type 2 Inflammation
Join Dr. Celeste Porsbjerg as she explores the mechanisms underlying mucus plugging development as mucociliary clearance. She explains how type 2 cytokines—particularly IL-13—impair this clearance mechanism, leading to mucus plugging, and worsened asthma outcomes.
View more
ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With <b>Asthma</b>
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
Unraveling the Link of Type 2 Inflammation and Airway Remodeling in <b>Asthma</b>
expert video

Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma

Type 2 Inflammation
Join Dr. Celeste Porsbjerg as she discussed on how type 2 inflammation may lead to airway remodeling in asthma, exploring the pathophysiologic mechanisms, that ultimately lead to structural changes and irreversible loss of lung function
View more
Monitoring Lung Function Is an Important Aspect of Pediatric <b>Asthma</b> Management
interactivity

Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management

Pulmonology
Navigate through this interactive infographic to learn more about why lung function is important to monitor in pediatric patients with asthma and the noninvasive procedures that are available for implementation in clinical practice.
View more
On-Treatment Clinical Remission in <b>Asthma</b> Patients Case Tool
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Pulmonology
Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.
View more
Adult <b>Asthma</b> Interactive Patient Cases
interactivity

Adult Asthma Interactive Patient Cases

Pulmonology
Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma
View more
Pediatric <b>Asthma</b> Patient Case Tool: Ash
interactivity

Pediatric Asthma Patient Case Tool: Ash

Pulmonology
Review a patient case to learn more about identifying uncontrolled asthma and type 2 inflammation in pediatric patients
View more
Multifaceted Role of IL-13 in Airway Remodeling
expert video

Multifaceted Role of IL-13 in Airway Remodeling

Type 2 Inflammation
Join Dr. Celeste Porsbjerg as she discusses on how IL-13 contributes to mucus plugging in asthma.
View more
EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission
expert video

EAACI 2024 Moving Beyond Control To On-Treatment Clinical Remission

Pulmonology
Watch Prof G. Walter Canonica discuss the need to move beyond disease control to clinical remission in asthma and CRSwNP.
View more
The Risks of Associated Systemic and Atopic Comorbidities with AD
expert video

The Risks of Associated Systemic and Atopic Comorbidities with AD

Dermatology
Dr. Paller explores the multifaceted impact of AD, highlighting its association with various comorbidities such as food allergies, asthma, allergic rhinitis, and mental health disorders.
View more
Clinical Manifestations Associated With Airway Remodeling in <b>Asthma</b>
expert video

Clinical Manifestations Associated With Airway Remodeling in Asthma

Type 2 Inflammation
Join Dr. Hanania to understand how to identify patients at risk of fixed airway obstruction in clinical settings.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: IndiaChange country/region